Syndax Pharmaceuticals Inc Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Syndax Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q2 2024.
  • Syndax Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 85.3M shares, a 22.5% increase year-over-year.
  • Syndax Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 70.4M shares, a 15.8% increase from 2022.
  • Syndax Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 60.8M shares, a 16.7% increase from 2021.
  • Syndax Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 52.1M shares, a 26% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 85.3M +15.6M +22.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 85.2M +15.8M +22.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 70.4M +9.61M +15.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 69.9M +9.19M +15.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 69.6M +9.48M +15.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 69.4M +10.5M +17.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 60.8M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 60.7M +8.71M +16.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 60.2M +8.55M +16.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 59M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q3 2021 52M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 51.6M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.